Invited commentary

International Association of Endocrine Surgeons—Manuscripts Presented at the 35th World Congress of the International Society of Surgery, Hong Kong, August 1993
Published: July 1994

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Dobyns, B.M., Sheline, C.E., Workman, J.B., et al.: Malignant and benign neoplasms of the thyroid patients treated for hyperthyroidism. J. Clin. Endocrinol. Metab. 38:976, 1974
Google Scholar
Halnan, K.E.: Radio-iodine treatment for hyperthyroidism-a more liberal policy? Clin. Endocrinol. Metab. 14:467, 1985
Google Scholar
Holm, L.E., Hall, P., Wiklund, K., et al.: Cancer risk after iodine-131 therapy for hyperthyroidism. J. Natl. Cancer Inst. 83:1072, 1991
Google Scholar
Hales, I.B., McElduff, A., Crummer, P., et al.: Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer. J. Clin. Endocrinol. Metab. 75:886, 1992
Google Scholar
Belfiore, A., Garofalo, M.R., Giuffrida, D., et al.: Increased aggressiveness of thyroid cancer in patients with Graves' disease. J. Clin. Endocrinol. Metab. 70:830, 1990
Google Scholar

Endocrine Surgical Unit, Uppsala University Hospital, S-751 85, Uppsala, Sweden
Jonas Rastad M.D.

Authors

Jonas Rastad M.D.
View author publications
You can also search for this author in PubMed Google Scholar

Rastad, J. Invited commentary. World J. Surg. 18, 528 (1994). https://doi.org/10.1007/BF00353755

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.